Document is current
Any future updates will be listed below
-
Authors
Pisula, Juan I.
Helbig, Doris
Sancéré, Lucas
Persa, Oana-Diana
Bürger, Corinna
Fröhlich, Anne
Lorenz, Carina
Bingmann, Sandra
Niebel, Dennis
Drexler, Konstantin
Landsberg, Jennifer
Thomas, Roman
Bozek, Katarzyna
Brägelmann, Johannes
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (70113307, 70113307)
Deutsche Forschungsgemeinschaft (CRC1399, project ID 413326622, CRC1399, project ID 413326622)
Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen (NW21-062B)
Bundesministerium für Bildung und Forschung (01ZX1917B, 01ZX1917B)
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 4 June 2025
First Online: 28 June 2025
Competing interests
: The Authors declare no Competing Non-Financial Interests but the following Competing Financial Interests: D.N. received financial support (speaker’s honoraria, advisory boards, travel expense reimbursements or grants) from Abbvie, Almirall, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers-Squib, GlaxoSmithKline, Incyte, Janssen-Cilag, Kyowa Kirin, LEO Pharma, Lilly, L’Oreal/Cerave, MSD, Novartis, Pfizer, Regeneron and UCB Pharma. J.B. received research funding from Bayer and travel expenses from Merck KG and Bicycle Therapeutics outside the presented work. K.D. received financial support (speaker’s honoraria, advisory boards, travel expense reimbursements or grants) from Abbvie, Bristol-Myers-Squib, Novartis, and Pierre-Fabre.
